…because it’s privatly held. Hopefully, they will go public and we can invest at some point (assuming they ever develop a viable product).
» …because it’s privatly held. Hopefully, they will go public and we can
» invest at some point (assuming they ever develop a viable product).
Does not matter. The chances are that it would be just wasted money. And no one here would invest in the end anyway
debris: …because it’s privatly held. Hopefully, they will go public and we can
invest at some point (assuming they ever develop a viable product).
Does not matter. The chances are that it would be just wasted money. And
no one here would invest in the end anyway
how so? I’d love to hear an explanation.
.
» …because it’s privatly held. Hopefully, they will go public and we can
» invest at some point (assuming they ever develop a viable product).
Not neccessarily. One of the chief investors in Follica is P&G, right? If so, buy some P&G stock. If Follica works, P&G will most certainly own a part of it.
investors are smart enough to valuate risks.
biotech companies (and especially the starting ones) are one of the most risky businesses out there.
also, it is very early (human trials have not been started yet), also, us economy is going dowhill currently.
All these factors mean, that even if it was public company, if you were buying now, then you could be sure that for the next 3 years it’s price will be lower than for what you have bought.
Look at ICX, they have product in phase 3, products in phase 2, the hair loss one seems to be really working, and the price? going down. it’s all about the money. all this is worth not too much until the company starts really making money of it.
debris:
investors are smart enough to valuate risks.
biotech companies (and especially the starting ones) are one of the most
risky businesses out there.
also, it is very early (human trials have not been started yet), also, us economy is going dowhill currently.
All these factors mean, that even if it was public company, if you were
buying now, then you could be sure that for the next 3 years it’s price
will be lower than for what you have bought.
Look at ICX, they have product in phase 3, products in phase 2, the hair
loss one seems to be really working, and the price? going down. it’s all
about the money. all this is worth not too much until the company starts
really making money of it.
Fair enough, we can label biotech firms high-risk ventures, but that’s a stark difference from calling them “wasted money”. Follica is, indeed, a high risk company, but associating it with “wasted money” denotes they’re nothing less than a sensational scam.
.
That’s it !